HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer
Open Access
- 1 November 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (21) , 6073-6085
Abstract
TGFβ signaling inhibits cell proliferation to block cancer initiation, yet it also enhances metastasis to promote malignancy during breast cancer development. The mechanisms underlying these differential effects are still unclear. Here, we report that HER2/EGFR signaling switches TGFβ function in breast cancer cells from antiproliferation to cancer promotion. Inhibition of HER2/EGFR activity attenuated TGFβ–induced epithelial–mesenchymal transition and migration but enhanced the antiproliferative activity of TGFβ. Activation of HER2/EGFR induced phosphorylation of Smad3 at Ser208 of the linker region through AKT, which promoted the nuclear accumulation of Smad3 and subsequent expression of the genes related to EMT and cell migration. In contrast, HER2/EGFR signaling had no effects on the nuclear localization of Smad2. Knockdown of Smad3, but not Smad2, blocked TGFβ–induced breast cancer cell migration. We observed a positive correlation between the nuclear localization of Smad3 and HER2 activation in advanced human breast cancers. Our results demonstrate a key role for HER2/EGFR in differential regulation of Smad3 activity to shift TGFβ function from antitumorigenic to protumorigenic during breast cancer development. Significance: TGFβ signaling can shift from inhibiting to promoting breast cancer development via HER2/EGFR AKT-mediated phosphorylation of Smad3 at S208, enhancing its nuclear accumulation and upregulation of EMT-related genes. Graphical http://cancerres.aacrjournals.org/content/canres/78/21/6073/F1.large.jpg. Cancer Res; 78(21); 6073–85. ©2018 AACR.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (31730056 and 31330049)
- Development Program of China (2017YFA0103601)
This publication has 50 references indexed in Scilit:
- When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) OncogeneJournal of Mammary Gland Biology and Neoplasia, 2011
- Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β PathwaysCell, 2009
- Transforming Growth Factor-β-inducible Phosphorylation of Smad3Journal of Biological Chemistry, 2009
- Nuclear Export of Smad2 and Smad3 by RanBP3 Facilitates Termination of TGF-β SignalingDevelopmental Cell, 2009
- Specific Activation of Mitogen-activated Protein Kinase by Transforming Growth Factor-β Receptors in Lipid Rafts Is Required for Epithelial Cell PlasticityMolecular Biology of the Cell, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- Phospho-control of TGF-β superfamily signalingCell Research, 2008
- TGFβ in CancerCell, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Phosphoproteomic analysis of Her2/neu signaling and inhibitionProceedings of the National Academy of Sciences, 2006